TY - JOUR
T1 - The clinical role of IL-23p19 in patients with rheumatoid arthritis
AU - Kim, H. R.
AU - Kim, H. S.
AU - Park, M. K.
AU - Cho, M. L.
AU - Lee, S. H.
AU - Kim, H. Y.
N1 - Funding Information:
This work was supported by a grant (R11-2002-098-05001-0) from the Korea Science and Engineering Foundation through the RhRC (Rheumatism Research Centre) at the Catholic University of Korea.
PY - 2007
Y1 - 2007
N2 - Objective: To determine the clinical implications of the over-expression of synovial and circulating interleukin (IL)-23p19 and the correlation between IL-23p19 and other cytokines such as IL-17, tumour necrosis factor (TNF)α, and IL-1β in rheumatoid arthritis (RA). Methods: Synovial fluid (SF) and sera of 22 patients with RA were obtained during knee arthrocentesis and stored at -20°C. Tender/swollen joint counts, 100-mm visual analogue scale (VAS), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), and antibodies to cyclic citrullinated peptide (anti-CCP Ab) were measured. Bony erosions were determined by X-rays. Serum and SF IL-23p19, IL-17, TNFα, and IL-1β concentrations were measured by sandwich enzyme-linked immunosorbent assay (ELISA). Results: The concentration of IL-23p19 correlated with the concentration of IL-17 in SF and sera, and with the concentrations of TNFα and IL-1β in sera. SF IL-23p19 concentration was higher in patients who had bony erosions than those who had not. However, there was no correlation between IL-23p19 concentrations and other clinical parameters of RA. Conclusion: Upregulated IL-23p19 in SF might be involved in joint destruction in RA through interplay with other cytokines such as IL-17, TNFα, and IL-1β.
AB - Objective: To determine the clinical implications of the over-expression of synovial and circulating interleukin (IL)-23p19 and the correlation between IL-23p19 and other cytokines such as IL-17, tumour necrosis factor (TNF)α, and IL-1β in rheumatoid arthritis (RA). Methods: Synovial fluid (SF) and sera of 22 patients with RA were obtained during knee arthrocentesis and stored at -20°C. Tender/swollen joint counts, 100-mm visual analogue scale (VAS), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), and antibodies to cyclic citrullinated peptide (anti-CCP Ab) were measured. Bony erosions were determined by X-rays. Serum and SF IL-23p19, IL-17, TNFα, and IL-1β concentrations were measured by sandwich enzyme-linked immunosorbent assay (ELISA). Results: The concentration of IL-23p19 correlated with the concentration of IL-17 in SF and sera, and with the concentrations of TNFα and IL-1β in sera. SF IL-23p19 concentration was higher in patients who had bony erosions than those who had not. However, there was no correlation between IL-23p19 concentrations and other clinical parameters of RA. Conclusion: Upregulated IL-23p19 in SF might be involved in joint destruction in RA through interplay with other cytokines such as IL-17, TNFα, and IL-1β.
UR - http://www.scopus.com/inward/record.url?scp=34548331593&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548331593&partnerID=8YFLogxK
U2 - 10.1080/03009740701286813
DO - 10.1080/03009740701286813
M3 - Article
C2 - 17763202
AN - SCOPUS:34548331593
SN - 0300-9742
VL - 36
SP - 259
EP - 264
JO - Scandinavian Journal of Rheumatology
JF - Scandinavian Journal of Rheumatology
IS - 4
ER -